| # | Title | Journal | Year | Citations |
|---|
| 1 | Botulinum Toxin as a Biological Weapon | JAMA - Journal of the American Medical Association | 2001 | 1,442 |
| 2 | Tularemia as a Biological Weapon | JAMA - Journal of the American Medical Association | 2001 | 1,255 |
| 3 | Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys | Nature | 2016 | 1,245 |
| 4 | Identification of Oxidative Stress and Toll-like Receptor 4 Signaling as a Key Pathway of Acute Lung Injury | Cell | 2008 | 1,164 |
| 5 | Ebola virus entry requires the cholesterol transporter Niemann–Pick C1 | Nature | 2011 | 1,127 |
| 6 | Smallpox as a Biological Weapon | JAMA - Journal of the American Medical Association | 1999 | 1,052 |
| 7 | Genomic analysis of diversity, population structure, virulence, and antimicrobial resistance in Klebsiella pneumoniae , an urgent threat to public health | Proceedings of the National Academy of Sciences of the United States of America | 2015 | 942 |
| 8 | Anthrax as a Biological Weapon, 2002 | JAMA - Journal of the American Medical Association | 2002 | 917 |
| 9 | Hantaviruses: A Global Disease Problem | Emerging Infectious Diseases | 1997 | 905 |
| 10 | Plague as a Biological Weapon | JAMA - Journal of the American Medical Association | 2000 | 903 |
| 11 | Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses | Nature Medicine | 2005 | 607 |
| 12 | Small molecule inhibitors reveal Niemann–Pick C1 is essential for Ebola virus infection | Nature | 2011 | 601 |
| 13 | Hemorrhagic Fever Viruses as Biological Weapons | JAMA - Journal of the American Medical Association | 2002 | 591 |
| 14 | An Update on the Potential of North American Mosquitoes (Diptera: Culicidae) to Transmit West Nile Virus | Journal of Medical Entomology | 2005 | 581 |
| 15 | Repurposing of Clinically Developed Drugs for Treatment of Middle East Respiratory Syndrome Coronavirus Infection | Antimicrobial Agents and Chemotherapy | 2014 | 564 |
| 16 | Vector Competence of North American Mosquitoes (Diptera: Culicidae) for West Nile Virus | Journal of Medical Entomology | 2001 | 537 |
| 17 | Clinical recognition and management of patients exposed to biological warfare agents | JAMA - Journal of the American Medical Association | 1997 | 528 |
| 18 | Performance comparison of generalized born and Poisson methods in the calculation of electrostatic solvation energies for protein structures | Journal of Computational Chemistry | 2004 | 523 |
| 19 | Microevolution and history of the plague bacillus, Yersinia pestis | Proceedings of the National Academy of Sciences of the United States of America | 2004 | 463 |
| 20 | Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates | Nature | 2003 | 436 |
| 21 | Pathology of Fatal West Nile Virus Infections in Native and Exotic Birds during the 1999 Outbreak in New York City, New York | Veterinary Pathology | 2000 | 429 |
| 22 | A Mouse Model for Evaluation of Prophylaxis and Therapy of Ebola Hemorrhagic Fever | Journal of Infectious Diseases | 1998 | 418 |
| 23 | Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study | Lancet, The | 2010 | 414 |
| 24 | Exotic emerging viral diseases: progress and challenges | Nature Medicine | 2004 | 411 |
| 25 | Taxonomy of the order Mononegavirales: update 2016 | Archives of Virology | 2016 | 407 |
| 26 | Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox | Nature | 2004 | 405 |
| 27 | Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization | Proceedings of the National Academy of Sciences of the United States of America | 2005 | 401 |
| 28 | Prospective, Double-Blind, Concurrent, Placebo-Controlled Clinical Trial of Intravenous Ribavirin Therapy of Hemorrhagic Fever with Renal Syndrome | Journal of Infectious Diseases | 1991 | 397 |
| 29 | Postexposure Prophylaxis against Experimental Inhalation Anthrax | Journal of Infectious Diseases | 1993 | 389 |
| 30 | Molecular Evidence of Sexual Transmission of Ebola Virus | New England Journal of Medicine | 2015 | 380 |
| 31 | An Orally Bioavailable Antipoxvirus Compound (ST-246) Inhibits Extracellular Virus Formation and Protects Mice from Lethal Orthopoxvirus Challenge | Journal of Virology | 2005 | 372 |
| 32 | Structural flexibility in the Burkholderia mallei genome | Proceedings of the National Academy of Sciences of the United States of America | 2004 | 366 |
| 33 | Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys | Lancet, The | 2003 | 362 |
| 34 | Smallpox vaccine–induced antibodies are necessary and sufficient for protection against monkeypox virus | Nature Medicine | 2005 | 346 |
| 35 | Virus genomes reveal factors that spread and sustained the Ebola epidemic | Nature | 2017 | 346 |
| 36 | Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques | Proceedings of the National Academy of Sciences of the United States of America | 2012 | 344 |
| 37 | DC-SIGN and DC-SIGNR Bind Ebola Glycoproteins and Enhance Infection of Macrophages and Endothelial Cells | Virology | 2003 | 338 |
| 38 | Mechanisms Underlying Coagulation Abnormalities in Ebola Hemorrhagic Fever: Overexpression of Tissue Factor in Primate Monocytes/Macrophages Is a Key Event | Journal of Infectious Diseases | 2003 | 336 |
| 39 | Dendrimer-RNA nanoparticles generate protective immunity against lethal Ebola, H1N1 influenza, and Toxoplasma gondii challenges with a single dose | Proceedings of the National Academy of Sciences of the United States of America | 2016 | 320 |
| 40 | Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge | Nature Medicine | 2014 | 311 |
| 41 | SEROTYPE-SPECIFIC DENGUE VIRUS CIRCULATION AND DENGUE DISEASE IN BANGKOK, THAILAND FROM 1973 TO 1999 | American Journal of Tropical Medicine and Hygiene | 2003 | 309 |
| 42 | Ovarian Tumor Domain-Containing Viral Proteases Evade Ubiquitin- and ISG15-Dependent Innate Immune Responses | Cell Host and Microbe | 2007 | 304 |
| 43 | Relationship of Preexisting Dengue Virus (DV) Neutralizing Antibody Levels to Viremia and Severity of Disease in a Prospective Cohort Study of DV Infection in Thailand | Journal of Infectious Diseases | 2004 | 302 |
| 44 | Panmicrobial Oligonucleotide Array for Diagnosis of Infectious Diseases | Emerging Infectious Diseases | 2007 | 298 |
| 45 | Genomic epidemiology reveals multiple introductions of Zika virus into the United States | Nature | 2017 | 298 |
| 46 | Purification and characterization of ciguatoxins from moray eel (Lycodontis javanicus, Muraenidae) | Toxicon | 1991 | 293 |
| 47 | Type VI secretion is a major virulence determinant inBurkholderia mallei | Molecular Microbiology | 2007 | 293 |
| 48 | Efficient production and enhanced tumor delivery of engineered extracellular vesicles | Biomaterials | 2016 | 286 |
| 49 | Taxonomy of the order Bunyavirales: update 2019 | Archives of Virology | 2019 | 285 |
| 50 | Ebola virus entry requires the host-programmed recognition of an intracellular receptor | EMBO Journal | 2012 | 284 |
